Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Greenland Mines Ltd received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
- Exchange
- nasdaq
- Notice
- compliance regained
- Deficiency
- stockholders equity
- Rules
- 5550(b)(1)
Exact text from the filing
July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Greenland Mines Ltd received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
- Exchange
- nasdaq
- Notice
- compliance regained
- Deficiency
- minimum bid price
- Rules
- 5550(a)(2)
Exact text from the filing
July 14, 2025, Klotho Neurosciences, Inc. (the “Company”), received a letter from the Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum $1.00 bid price under NASDAQ Listing Rule 5550(a)(2), and the minimum stockholders’ equity threshold of $2.5 million under Listing Rule 5550(b)(1). In addition, on July 14. 2025, Nasdaq approved the Company’s application to “phase down” the listing of its common stock and warrants from the Nasdaq Global Market to the Nasdaq Capital Market. The Company’s common stock will continue to trade under
View on SEC.gov